Service universitaire de psychiatrie de l’âge avancé (SUPAA), Hôpital de Cery, Prilly, Suisse
Consultations mémoire, CH Le Vinatier, Bron, France
Unité d’addictologie et Consultation mémoire, CH les Chanaux, Mâcon, France
Institut de psychologie, Université Lyon 2, Laboratoire Diphe, Bron, France
Équipe mobile Maladie d’Alzheimer, CH Les Charpennes, Villeurbanne, France
Service universitaire d’addictologie de Lyon (SUAL), CH Le Vinatier, Bron, France
Université de Lyon, UCBL, Centre de recherche en neurosciences de Lyon (CRNL), Inserm U1028, CNRS UMR5292, PSYR2, Bron, France
Analgesic opioids addiction (AOA) is very frequent in the elderly, and results in a high morbi-mortality due to geriatric associated pathologies with pharmacokinetics modifications. However, it is poorly detected in these subjects and specific screening tools should be widely used to detect the risk factors for AOA prevention. Before initiating opioid prescription, exhaustive search of associated treatments (to track drug interaction) and of opioid prescription by other clinicians (doctor shopping) are requisite.Specific care sectors, as developed in the United States are still scarce in France and care support is provided by the collaboration between geriatricians and psychiatrists. Optimisation of somatic and psychiatric comorbidities is a core part of the guidelines.